The ROE as of December 2024 (TTM) for Phio Pharmaceuticals Corp. (PHIO) is -134.57%

According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current ROE is -134.57%. This represents a change of 277.23% compared to the average of -35.67% of the last 4 quarters.

Phio Pharmaceuticals Corp. (PHIO) Historical ROE (quarterly & annually)

How has PHIO ROE performed in the past?

The mean historical ROE of Phio Pharmaceuticals Corp. over the last ten years is -177.79%. The current -134.57% ROE has changed -24.31% with respect to the historical average. Over the past ten years (40 quarters), PHIO's ROE was at its highest in in the June 2021 quarter at -9.32%. The ROE was at its lowest in in the March 2018 quarter at -394.89%.

Phio Pharmaceuticals Corp. (PHIO) ROE by Quarter and Year

Discovering the peaks and valleys of Phio Pharmaceuticals Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Phio Pharmaceuticals Corp. (PHIO) Average ROE

How has PHIO ROE performed in the past?

The current ROE of Phio Pharmaceuticals Corp. (PHIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Phio Pharmaceuticals Corp. (PHIO) ROE vs. Peers

How is PHIO’s ROE compared to its peers?

Phio Pharmaceuticals Corp.’s ROE is greater than Zura Bio Limited (-39.61%), less than Apexigen, Inc. (48.27%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Immix Biopharma, Inc. (-102.10%), less than CNS Pharmaceuticals, Inc. (695.91%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than VectivBio Holding AG (-56.92%), less than AVROBIO, Inc. (29.68%), greater than CohBar, Inc. (-58.44%), less than Ocean Biomedical, Inc. (75.64%), greater than Elevation Oncology, Inc. (-59.73%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than 180 Life Sciences Corp. (-559.06%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%),

Build a custom stock screener for Phio Pharmaceuticals Corp. (PHIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Phio Pharmaceuticals Corp. (PHIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.